Preclinical programs

TW002: AAV5-GDNF gene therapy. GDNF is a neurotrophic factor with neuroprotective properties. Proof of Concept studies with TW002 are currently ongoing. TW002 is being developed in collaboration with uniQure.

Skills

Posted on

January 10, 2018